Global private equity and venture capital news and research

Posts Tagged ‘AVG Ventures’

8 January 2014

AVG Ventures, Remeditex help cancer treatment company Bellicum to $34.4m Series B

AVG Ventures and Remeditex Ventures have increased their backing of Bellicum Pharmaceuticals to help it raise $34.4m for its Series B round.

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016